MeSH D007177 - inappropriate adh syndrome
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Accord Healthcare | Tolvaptan | Tolvaptan Accord | ||||
| Otsuka | Tolvaptan | Samsca | 2009-08-02 |
Clinical Trials
Historical Success Rate
Phase 1
100%1/1
Phase 2
100%3/3
Phase 3
80%4/5
Approved: 2Overall Success rate: 80%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use